Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 269

1.

Effectiveness of different combinations of DMARDs and glucocorticoid bridging in early rheumatoid arthritis: two-year results of CareRA.

Stouten V, Westhovens R, Pazmino S, De Cock D, Van der Elst K, Joly J, Verschueren P; CareRA study group .

Rheumatology (Oxford). 2019 Jun 24. pii: kez213. doi: 10.1093/rheumatology/kez213. [Epub ahead of print]

PMID:
31236568
2.

Antinuclear antibodies by indirect immunofluorescence and solid phase assays.

Bossuyt X, Claessens J, De Langhe E, Belmondo T, Westhovens R, Hue S, Poesen K, Blockmans D, Mahler M, Fritzler MJ.

Ann Rheum Dis. 2019 May 10. pii: annrheumdis-2019-215443. doi: 10.1136/annrheumdis-2019-215443. [Epub ahead of print] No abstract available.

PMID:
31076390
3.

Patient reported outcome data from the Care in Early Rheumatoid Arthritis trial: Opportunities for broadening the scope of treating to target.

Van der Elst K, Verschueren P, Stouten V, Pazmino S, De Groef A, De Cock D, Joly J, Moons P, Westhovens R.

Arthritis Care Res (Hoboken). 2019 Apr 5. doi: 10.1002/acr.23900. [Epub ahead of print]

PMID:
30951267
4.

European Qualitative research project on Patient-preferred outcomes in Early Rheumatoid Arthritis (EQPERA): rationale, design and methods of a multinational, multicentre, multilingual, longitudinal qualitative study.

Van der Elst K, Bremander A, De Groef A, Larsson I, Mathijssen EGE, Vriezekolk JE, Westhovens R, van Eijk-Hustings YJL.

BMJ Open. 2019 Mar 27;9(3):e023606. doi: 10.1136/bmjopen-2018-023606.

5.

Mobile Health Features Supporting Self-Management Behavior in Patients With Chronic Arthritis: Mixed-Methods Approach on Patient Preferences.

Geuens J, Geurts L, Swinnen TW, Westhovens R, Vanden Abeele V.

JMIR Mhealth Uhealth. 2019 Mar 25;7(3):e12535. doi: 10.2196/12535.

6.

Clinical efficacy of new JAK inhibitors under development. Just more of the same?

Westhovens R.

Rheumatology (Oxford). 2019 Feb 1;58(Supplement_1):i27-i33. doi: 10.1093/rheumatology/key256.

7.

Treatment adherence in systemic sclerosis: A cross-sectional study.

Brijs J, Arat S, Westhovens R, Lenaerts JL, De Langhe E.

Musculoskeletal Care. 2019 Mar;17(1):44-53. doi: 10.1002/msc.1363. Epub 2018 Oct 9.

PMID:
30298974
8.

Rituximab in systemic autoimmune rheumatic diseases: indications and practical use.

Berghen N, Vulsteke JB, Westhovens R, Lenaerts J, De Langhe E.

Acta Clin Belg. 2019 Aug;74(4):272-279. doi: 10.1080/17843286.2018.1521904. Epub 2018 Sep 26.

PMID:
30253707
9.

Improvements in productivity and increased participation in daily activities over 52 weeks of certolizumab pegol treatment of rheumatoid arthritis: results of a Belgian observational study.

Westhovens R, Ravelingien I, Vandevyvere K, Pansar I, Purcaru O, Kumke T, Gyselbrecht L.

Acta Clin Belg. 2018 Aug 30:1-9. doi: 10.1080/17843286.2018.1509923. [Epub ahead of print]

PMID:
30160189
10.

Widespread pain in axial spondyloarthritis: clinical importance and gender differences.

Swinnen TW, Westhovens R, Dankaerts W, de Vlam K.

Arthritis Res Ther. 2018 Jul 27;20(1):156. doi: 10.1186/s13075-018-1626-8.

11.

A multi-criteria decision approach for ranking unmet needs in healthcare.

Cleemput I, Devriese S, Kohn L, Westhovens R.

Health Policy. 2018 Aug;122(8):878-884. doi: 10.1016/j.healthpol.2018.06.010. Epub 2018 Jun 30.

PMID:
29983193
12.

Antinuclear antibody as entry criterion for classification of systemic lupus erythematosus: pitfalls and opportunities.

Willems P, De Langhe E, Westhovens R, Vanderschueren S, Blockmans D, Bossuyt X.

Ann Rheum Dis. 2019 Aug;78(8):e76. doi: 10.1136/annrheumdis-2018-213821. Epub 2018 Jun 23. No abstract available.

PMID:
29936439
13.

Spondyloarthritis in the Democratic Republic of the Congo: a prospective hospital-based study.

Lebughe P, de Vlam K, Westhovens R, Mbuyi-Muamba JM, Malemba JJ.

BMJ Open. 2018 May 9;8(5):e020329. doi: 10.1136/bmjopen-2017-020329.

14.

Conversion to seronegative status after abatacept treatment in patients with early and poor prognostic rheumatoid arthritis is associated with better radiographic outcomes and sustained remission: post hoc analysis of the AGREE study.

Jansen DTSL, Emery P, Smolen JS, Westhovens R, Le Bars M, Connolly SE, Ye J, Toes REM, Huizinga TWJ.

RMD Open. 2018 Mar 30;4(1):e000564. doi: 10.1136/rmdopen-2017-000564. eCollection 2018.

15.

Effect of filgotinib, a selective JAK 1 inhibitor, with and without methotrexate in patients with rheumatoid arthritis: patient-reported outcomes.

Genovese M, Westhovens R, Meuleners L, Van der Aa A, Harrison P, Tasset C, Kavanaugh A.

Arthritis Res Ther. 2018 Mar 23;20(1):57. doi: 10.1186/s13075-018-1541-z.

16.

Solid phase assays versus automated indirect immunofluorescence for detection of antinuclear antibodies.

Claessens J, Belmondo T, De Langhe E, Westhovens R, Poesen K, Hüe S, Blockmans D, Mahler M, Fritzler MJ, Bossuyt X.

Autoimmun Rev. 2018 Jun;17(6):533-540. doi: 10.1016/j.autrev.2018.03.002. Epub 2018 Mar 8. Review.

PMID:
29526634
17.

Cardiac transplantation in systemic sclerosis: single-centre experience of three cases.

Lenaerts JC, Lenaerts JL, Westhovens R, Droogne W, Ciarka A, Van Cleemput J, De Langhe E.

Rheumatology (Oxford). 2018 Jun 1;57(6):1120-1122. doi: 10.1093/rheumatology/key048. No abstract available.

PMID:
29522189
18.

High prevalence of occupational exposure to solvents or silica in male systemic sclerosis patients: a Belgian cohort analysis.

De Decker E, Vanthuyne M, Blockmans D, Houssiau F, Lenaerts J, Westhovens R, Nemery B, De Langhe E.

Clin Rheumatol. 2018 Jul;37(7):1977-1982. doi: 10.1007/s10067-018-4045-y. Epub 2018 Feb 23.

PMID:
29476353
19.

Illness Identity in Adults with a Chronic Illness.

Oris L, Luyckx K, Rassart J, Goubert L, Goossens E, Apers S, Arat S, Vandenberghe J, Westhovens R, Moons P.

J Clin Psychol Med Settings. 2018 Dec;25(4):429-440. doi: 10.1007/s10880-018-9552-0.

PMID:
29468569
20.

Detection of myositis-specific antibodies.

Vulsteke JB, De Langhe E, Claeys KG, Dillaerts D, Poesen K, Lenaerts J, Westhovens R, Van Damme P, Blockmans D, De Haes P, Bossuyt X.

Ann Rheum Dis. 2019 Jan;78(1):e7. doi: 10.1136/annrheumdis-2017-212915. Epub 2018 Jan 25. No abstract available.

PMID:
29371203
21.

Modifiable correlates of illness perceptions in adults with chronic somatic conditions: A systematic review.

Arat S, De Cock D, Moons P, Vandenberghe J, Westhovens R.

Res Nurs Health. 2018 Apr;41(2):173-184. doi: 10.1002/nur.21852. Epub 2018 Jan 9. Review.

PMID:
29315678
22.

Screening for connective tissue disease-associated antibodies by automated immunoassay.

Willems P, De Langhe E, Claessens J, Westhovens R, Van Hoeyveld E, Poesen K, Vanderschueren S, Blockmans D, Bossuyt X.

Clin Chem Lab Med. 2018 May 24;56(6):909-918. doi: 10.1515/cclm-2017-0905.

PMID:
29306915
23.

Identification of biomarkers of response to abatacept in patients with SLE using deconvolution of whole blood transcriptomic data from a phase IIb clinical trial.

Bandyopadhyay S, Connolly SE, Jabado O, Ye J, Kelly S, Maldonado MA, Westhovens R, Nash P, Merrill JT, Townsend RM.

Lupus Sci Med. 2017 Jul 28;4(1):e000206. doi: 10.1136/lupus-2017-000206. eCollection 2017.

24.

Illness representations of systemic lupus erythematosus and systemic sclerosis: a comparison of patients, their rheumatologists and their general practitioners.

Arat S, Lenaerts JL, De Langhe E, Verschueren P, Moons P, Vandenberghe J, Taelman V, Westhovens R.

Lupus Sci Med. 2017 Nov 14;4(1):e000232. doi: 10.1136/lupus-2017-000232. eCollection 2017.

25.

Activity Limitations in Patients with Axial Spondyloarthritis: A Role for Fear of Movement and (Re)injury Beliefs.

Swinnen TW, Vlaeyen JWS, Dankaerts W, Westhovens R, de Vlam K.

J Rheumatol. 2018 Mar;45(3):357-366. doi: 10.3899/jrheum.170318. Epub 2017 Nov 15.

PMID:
29142031
26.

The use of glucocorticoids in early rheumatoid arthritis.

Verschueren P, Westhovens R.

Rheumatology (Oxford). 2018 Aug 1;57(8):1316-1317. doi: 10.1093/rheumatology/kex271. Review. No abstract available.

PMID:
28968687
27.

Perception of Originator Biologics and Biosimilars: A Survey Among Belgian Rheumatoid Arthritis Patients and Rheumatologists.

van Overbeeke E, De Beleyr B, de Hoon J, Westhovens R, Huys I.

BioDrugs. 2017 Oct;31(5):447-459. doi: 10.1007/s40259-017-0244-3.

PMID:
28929342
28.

Two years follow-up of an open-label pilot study of treatment with rituximab in patients with early diffuse cutaneous systemic sclerosis.

Melsens K, Vandecasteele E, Deschepper E, Badot V, Blockmans D, Brusselle G, De Langhe E, De Pauw M, Debusschere C, Decuman S, Deroo L, Houssiau F, Lenaerts J, Piette Y, Thevissen K, Vanthuyne M, Westhovens R, Wijnant S, De Keyser F, Smith V.

Acta Clin Belg. 2018 Apr;73(2):119-125. doi: 10.1080/17843286.2017.1372244. Epub 2017 Sep 11.

PMID:
28891418
29.

The Dutch-Flemish PROMIS Physical Function item bank exhibited strong psychometric properties in patients with chronic pain.

Crins MHP, Terwee CB, Klausch T, Smits N, de Vet HCW, Westhovens R, Cella D, Cook KF, Revicki DA, van Leeuwen J, Boers M, Dekker J, Roorda LD.

J Clin Epidemiol. 2017 Jul;87:47-58. doi: 10.1016/j.jclinepi.2017.03.011. Epub 2017 Mar 28.

PMID:
28363734
30.

A Rare Cause of Weight Loss in an 80y Old Ankylosing Spondylitis Patient.

Westhovens I, Thielens I, De Vlam K, Westhovens R, Delva T.

J Clin Rheumatol. 2017 Apr;23(3):170-171. doi: 10.1097/RHU.0000000000000505. No abstract available.

PMID:
28277346
31.

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update.

Smolen JS, Landewé R, Bijlsma J, Burmester G, Chatzidionysiou K, Dougados M, Nam J, Ramiro S, Voshaar M, van Vollenhoven R, Aletaha D, Aringer M, Boers M, Buckley CD, Buttgereit F, Bykerk V, Cardiel M, Combe B, Cutolo M, van Eijk-Hustings Y, Emery P, Finckh A, Gabay C, Gomez-Reino J, Gossec L, Gottenberg JE, Hazes JMW, Huizinga T, Jani M, Karateev D, Kouloumas M, Kvien T, Li Z, Mariette X, McInnes I, Mysler E, Nash P, Pavelka K, Poór G, Richez C, van Riel P, Rubbert-Roth A, Saag K, da Silva J, Stamm T, Takeuchi T, Westhovens R, de Wit M, van der Heijde D.

Ann Rheum Dis. 2017 Jun;76(6):960-977. doi: 10.1136/annrheumdis-2016-210715. Epub 2017 Mar 6. Review.

32.

Diverging illness perceptions between physicians about patients with systemic lupus erythematosus and systemic sclerosis: a vignette-based study.

Arat S, Moons P, Vandenberghe J, Lenaerts JL, de Vlam K, Westhovens R.

Rheumatol Int. 2017 Jun;37(6):915-922. doi: 10.1007/s00296-017-3667-8. Epub 2017 Feb 28.

PMID:
28246961
33.

Accelerometry-Based Activity Recognition and Assessment in Rheumatic and Musculoskeletal Diseases.

Billiet L, Swinnen TW, Westhovens R, de Vlam K, Van Huffel S.

Sensors (Basel). 2016 Dec 16;16(12). pii: E2151. doi: 10.3390/s16122151.

34.

Filgotinib (GLPG0634/GS-6034), an oral JAK1 selective inhibitor, is effective in combination with methotrexate (MTX) in patients with active rheumatoid arthritis and insufficient response to MTX: results from a randomised, dose-finding study (DARWIN 1).

Westhovens R, Taylor PC, Alten R, Pavlova D, Enríquez-Sosa F, Mazur M, Greenwald M, Van der Aa A, Vanhoutte F, Tasset C, Harrison P.

Ann Rheum Dis. 2017 Jun;76(6):998-1008. doi: 10.1136/annrheumdis-2016-210104. Epub 2016 Dec 19.

35.

A Nationwide Survey on Patient's versus Physician´s Evaluation of Biological Therapy in Rheumatoid Arthritis in Relation to Disease Activity and Route of Administration: The Be-Raise Study.

De Mits S, Lenaerts J, Vander Cruyssen B, Mielants H, Westhovens R, Durez P, Elewaut D; Be-Raise study group.

PLoS One. 2016 Nov 28;11(11):e0166607. doi: 10.1371/journal.pone.0166607. eCollection 2016.

36.

A Review of Persuasive Principles in Mobile Apps for Chronic Arthritis Patients: Opportunities for Improvement.

Geuens J, Swinnen TW, Westhovens R, de Vlam K, Geurts L, Vanden Abeele V.

JMIR Mhealth Uhealth. 2016 Oct 13;4(4):e118.

37.

Costs of drugs for treatment of rheumatic diseases.

Westhovens R, Annemans L.

RMD Open. 2016 Sep 12;2(2):e000259. doi: 10.1136/rmdopen-2016-000259. eCollection 2016.

38.

Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study.

Musset L, Allenbach Y, Benveniste O, Boyer O, Bossuyt X, Bentow C, Phillips J, Mammen A, Van Damme P, Westhovens R, Ghirardello A, Doria A, Choi MY, Fritzler MJ, Schmeling H, Muro Y, García-De La Torre I, Ortiz-Villalvazo MA, Bizzaro N, Infantino M, Imbastaro T, Peng Q, Wang G, Vencovský J, Klein M, Krystufkova O, Franceschini F, Fredi M, Hue S, Belmondo T, Danko K, Mahler M.

Autoimmun Rev. 2016 Oct;15(10):983-93. doi: 10.1016/j.autrev.2016.07.023. Epub 2016 Aug 1. Review.

PMID:
27491568
39.

Effectiveness of methotrexate with step-down glucocorticoid remission induction (COBRA Slim) versus other intensive treatment strategies for early rheumatoid arthritis in a treat-to-target approach: 1-year results of CareRA, a randomised pragmatic open-label superiority trial.

Verschueren P, De Cock D, Corluy L, Joos R, Langenaken C, Taelman V, Raeman F, Ravelingien I, Vandevyvere K, Lenaerts J, Geens E, Geusens P, Vanhoof J, Durnez A, Remans J, Vander Cruyssen B, Van Essche E, Sileghem A, De Brabanter G, Joly J, Meyfroidt S, Van der Elst K, Westhovens R.

Ann Rheum Dis. 2017 Mar;76(3):511-520. doi: 10.1136/annrheumdis-2016-209212. Epub 2016 Jul 18.

PMID:
27432356
40.

Instrumented BASFI (iBASFI) Shows Promising Reliability and Validity in the Assessment of Activity Limitations in Axial Spondyloarthritis.

Swinnen TW, Milosevic M, Van Huffel S, Dankaerts W, Westhovens R, de Vlam K.

J Rheumatol. 2016 Aug;43(8):1532-40. doi: 10.3899/jrheum.150439. Epub 2016 Jun 15. Erratum in: J Rheumatol. 2016 Aug;43(8):1618.

PMID:
27307537
41.

Development and preliminary evaluation of the validity and reliability of a revised illness perception questionnaire for healthcare professionals.

Arat S, Van den Zegel A, Van Rillaer M, Moons P, Vandenberghe J, De Langhe E, Westhovens R.

BMC Nurs. 2016 Jun 1;15:34. doi: 10.1186/s12912-016-0156-4. eCollection 2016.

42.

Separately tackling the development of erosions with denosumab: ultimately closing a gap in the treatment of patients with rheumatoid arthritis or trying too hard too late?

Verschueren P, Westhovens R.

Ann Rheum Dis. 2016 Jun;75(6):947-9. doi: 10.1136/annrheumdis-2015-208863. Epub 2016 Feb 9. No abstract available.

PMID:
26861701
43.

Unraveling Patient-Preferred Health and Treatment Outcomes in Early Rheumatoid Arthritis: A Longitudinal Qualitative Study.

van der Elst K, Meyfroidt S, De Cock D, De Groef A, Binnard E, Moons P, Verschueren P, Westhovens R.

Arthritis Care Res (Hoboken). 2016 Sep;68(9):1278-87. doi: 10.1002/acr.22824. Epub 2016 Jul 29.

44.

A general practice perspective on early rheumatoid arthritis management: A qualitative study from Flanders.

Meyfroidt S, Stevens J, De Lepeleire J, Westhovens R, De Cock D, Van der Elst K, Vanhaecht K, Verschueren P.

Eur J Gen Pract. 2015;21(4):231-7. doi: 10.3109/13814788.2015.1084279. Epub 2015 Nov 19.

PMID:
26679974
45.

Patients' Perceptions of their Rheumatic Condition: Why Does it Matter and How Can Healthcare Professionals Influence or Deal with these Perceptions?

Arat S, Vandenberghe J, Moons P, Westhovens R.

Musculoskeletal Care. 2016 Sep;14(3):174-9. doi: 10.1002/msc.1128. Epub 2015 Dec 8. No abstract available.

PMID:
26643587
46.

Are illness perception and coping style associated with the delay between symptom onset and the first general practitioner consultation in early rheumatoid arthritis management? An exploratory study within the CareRA trial.

Van der Elst K, De Cock D, Vecoven E, Arat S, Meyfroidt S, Joly J, Moons P, Verschueren P, Westhovens R, CareRA Study Group.

Scand J Rheumatol. 2016;45(3):171-8. doi: 10.3109/03009742.2015.1074278. Epub 2015 Sep 23.

PMID:
26399601
47.

Difficulties in diagnosis of systemic sclerosis-related interstitial lung disease.

Vrancken A, De Langhe E, Westhovens R, Yserbyt J, Cottin V, Wuyts W.

Respirol Case Rep. 2015 Sep;3(3):99-101. doi: 10.1002/rcr2.113. Epub 2015 Jun 8.

48.

The clinical impact of a brief transition programme for young people with juvenile idiopathic arthritis: results of the DON'T RETARD project.

Hilderson D, Moons P, Van der Elst K, Luyckx K, Wouters C, Westhovens R.

Rheumatology (Oxford). 2016 Jan;55(1):133-42. doi: 10.1093/rheumatology/kev284. Epub 2015 Aug 28.

PMID:
26320142
49.

Malignancies and anti-TNF therapy in rheumatoid arthritis: a single-center observational cohort study.

Berghen N, Teuwen LA, Westhovens R, Verschueren P.

Clin Rheumatol. 2015 Oct;34(10):1687-95. doi: 10.1007/s10067-015-3026-7. Epub 2015 Jul 30.

PMID:
26219489
50.

Calibration and Validation of the Dutch-Flemish PROMIS Pain Interference Item Bank in Patients with Chronic Pain.

Crins MH, Roorda LD, Smits N, de Vet HC, Westhovens R, Cella D, Cook KF, Revicki D, van Leeuwen J, Boers M, Dekker J, Terwee CB.

PLoS One. 2015 Jul 27;10(7):e0134094. doi: 10.1371/journal.pone.0134094. eCollection 2015.

Supplemental Content

Loading ...
Support Center